While sequencing the exomes of patients with rare diseases may end their diagnostic odysseys and possibly offer treatment ideas, insurers are beginning to re-think reimbursing such tests, Reuters reports. Insurance companies argue that there is no proof that sequencing results will lead to "meaningful treatments," the news agency adds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.